Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden

被引:7
|
作者
Bergman, Karin [1 ,2 ]
Harnqvist, Tor [1 ,3 ]
Backhaus, Erik [4 ]
Trollfors, Birger [5 ]
Dahl, Mats S. [6 ]
Kolberg, Helena [3 ]
Ockborn, Gunilla [7 ]
Andersson, Rune [1 ,8 ]
Karlsson, Johanna [1 ,3 ]
Mellgren, Asa [1 ,9 ]
Skovbjerg, Susann [1 ,8 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden
[2] South Alvsborg Hosp, Dept Infect Dis, SE-50182 Boras, Region Vastra G, Sweden
[3] North Alvsborg Uddevalla Hosp Grp, Dept Infect Dis, Trollhattan, Region Vastra G, Sweden
[4] Skaraborg Hosp, Dept Infect Dis, Skovde, Region Vastra G, Sweden
[5] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Region Vastra G, Sweden
[6] Narhalsan Management Grp, Gothenburg, Region Vastra G, Sweden
[7] Dept Communicable Dis Control, Boras, Region Vastra G, Sweden
[8] Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Region Vastra G, Sweden
[9] Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Region Vastra G, Sweden
关键词
Invasive pneumococcal disease; Pneumococcal infections; Pneumococcal serotype; Pneumococcal conjugated vaccine; PCV13; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CEREBROSPINAL-FLUID; ASSOCIATION; INFECTIONS; STRAINS; IMPACT; BLOOD;
D O I
10.1186/s12879-021-06430-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe pneumococcal conjugate vaccine PCV7 was introduced in Southwest Sweden in the child vaccination program in 2009, followed by PCV13 in 2010 and PCV10 in 2015. In this retrospective cohort study we assessed the pneumococcal serotype distribution in relation to predisposing factors, clinical manifestations and outcome during seven years after PCV introduction.MethodsClinical data from 1278 patients with 1304 episodes of invasive pneumococcal disease (IPD) between January 2009 and December 2015 in Region Vastra Gotaland, Sweden, were retrospectively collected from medical records. Pneumococcal isolates were serotyped by gel diffusion and/or Quellung reactions performed at the Public Health Agency in Sweden. Associations between serotypes and clinical characteristics were statistically evaluated by use of Fisher's exact test, Mann-Whitney U test and Logistic regression analysis, whereas IPD episodes caused by serotypes over time were analyzed by Mantel-Haenszel chi-square test.ResultsWith the exception of serotype 3, the prevalence of PCV13 serotypes decreased during the study period, from 76% (n=157) of all IPD episodes in 2009 to 25% (n=42) in 2015 (p<0.001) while non-PCV13 serotypes increased, mainly among patients <greater than or equal to>65years and in patients with predisposing factors, including cardiovascular disease, pulmonary disease and malignancy (p<0.001 for all). Patients with predisposing factors, including those with malignancy, immune deficiency or renal disease, were more likely to have IPD caused by a serotype not included in PCV13 rather than a vaccine-included serotype. Serotype 3 was associated with intensive care unit admissions while serotype 1 and 7F caused IPD among healthier and younger patients. PCV13 serotypes were associated with invasive pneumonia, and non-PCV13 serotypes were associated with bacteremia with unknown focus and with manifestations other than pneumonia or meningitis.ConclusionsNon-PCV13 serotypes caused the majority of IPD cases in Southwest Sweden, especially in patients <greater than or equal to>65years and in patients with predisposing factors. Serotype 3, included in PCV13, was prevalent and often caused severe disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
    Karin Bergman
    Tor Härnqvist
    Erik Backhaus
    Birger Trollfors
    Mats S. Dahl
    Helena Kolberg
    Gunilla Ockborn
    Rune Andersson
    Johanna Karlsson
    Åsa Mellgren
    Susann Skovbjerg
    [J]. BMC Infectious Diseases, 21
  • [2] Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease
    John, James
    Varghese, Rosemol
    Lionell, Jones
    Neeravi, Ayyanraj
    Veeraraghavan, Balaji
    [J]. INDIAN PEDIATRICS, 2018, 55 (10) : 874 - 876
  • [3] Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease
    James John
    Rosemol Varghese
    Jones Lionell
    Ayyanraj Neeravi
    Balaji Veeraraghavan
    [J]. Indian Pediatrics, 2018, 55 : 874 - 876
  • [4] Pneumococcal disease and non-vaccine serotypes
    Singleton, R. J.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2007, 97 (06): : 430 - 430
  • [5] The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark
    Slotved, Hans-Christian
    Dalby, Tine
    Hoffmann, Steen
    [J]. VACCINE, 2016, 34 (06) : 769 - 774
  • [6] Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of the 7-valent conjugate vaccine
    Gonzalez Martinez, F.
    Navarro Gomez, M. L.
    Saavedra Lozano, J.
    Santos Sebastian, M. M.
    Rodriguez Fernandez, R.
    Gonzalez Sanchez, M.
    Cercenado Mansilla, E.
    Hernandez-Sampelayo Matos, T.
    [J]. ANALES DE PEDIATRIA, 2014, 80 (03): : 173 - 180
  • [7] Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types
    Browall, Sarah
    Backhaus, Erik
    Naucler, Pontus
    Galanis, Ilias
    Sjostrom, Karin
    Karlsson, Diana
    Berg, Stefan
    Luthander, Joachim
    Eriksson, Margareta
    Spindler, Carl
    Ejdeback, Mikael
    Trollfors, Birger
    Darenberg, Jessica
    Kalin, Mats
    Ortqvist, Ake
    Andersson, Rune
    Henriques-Normark, Birgitta
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (06) : 1646 - 1657
  • [8] Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia
    Burgos, J.
    Falco, V.
    Borrego, A.
    Sorde, R.
    Larrosa, M. N.
    Martinez, X.
    Planes, A. M.
    Sanchez, A.
    Palomar, M.
    Rello, J.
    Pahissa, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 385 - 391
  • [9] Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
    van Hoek, Albert Jan
    Andrews, Nick
    Waight, Pauline A.
    George, Robert
    Miller, Elizabeth
    [J]. PLOS ONE, 2012, 7 (07):
  • [10] Pneumococcal invasive isolates of non-vaccine serotypes in Italy, 1999-2003 (pre-vaccine era)
    Gherardi, G.
    Monaco, M.
    Camilli, R.
    D'Ambrosio, F.
    D'Ancona, P.
    Manganelli, R.
    Dicuonzo, G.
    Pantosti, A.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S265 - S265